Great Valley Advisor Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.9M Buy
22,391
+1,140
+5% +$1.16M 0.42% 61
2026
Q1
$19.5M Buy
21,251
+2,239
+12% +$2.27M 0.36% 72
2025
Q4
$20.4M Sell
19,012
-605
-3% -$578K 0.39% 67
2025
Q3
$15M Buy
19,617
+1,680
+9% +$1.25M 0.3% 84
2025
Q2
$14M Sell
17,937
-5,429
-23% -$4.22M 0.31% 84
2025
Q1
$19.3M Sell
23,366
-1,390
-6% -$1.16M 0.42% 62
2024
Q4
$19.1M Buy
24,756
+1,662
+7% +$1.38M 0.43% 60
2024
Q3
$20.5M Buy
23,094
+1,717
+8% +$1.54M 0.5% 50
2024
Q2
$19.4M Buy
21,377
+1,083
+5% +$866K 0.54% 42
2024
Q1
$15.8M Buy
20,294
+3,338
+20% +$2.38M 0.48% 54
2023
Q4
$9.88M Sell
16,956
-1,672
-9% -$976K 0.35% 70
2023
Q3
$10M Buy
18,628
+688
+4% +$355K 0.41% 63
2023
Q2
$8.41M Sell
17,940
-1,008
-5% -$423K 0.35% 70
2023
Q1
$6.51M Sell
18,948
-6,142
-24% -$2.07M 0.3% 89
2022
Q4
$9.18M Buy
25,090
+7,919
+46% +$2.81M 0.47% 49
2022
Q3
$5.55M Sell
17,171
-4,748
-22% -$1.5M 0.31% 79
2022
Q2
$7.11M Buy
21,919
+8,313
+61% +$2.5M 0.39% 62
2022
Q1
$3.89M Buy
13,606
+373
+3% +$96K 0.23% 111
2021
Q4
$3.6M Buy
13,233
+133
+1% +$33.7K 0.22% 116
2021
Q3
$3.03M Buy
13,100
+623
+5% +$154K 0.21% 123
2021
Q2
$2.82M Sell
12,477
-710
-5% -$143K 0.21% 125
2021
Q1
$2.46M Sell
13,187
-5,389
-29% -$1.05M 0.24% 100
2020
Q4
$3.14M Buy
18,576
+876
+5% +$131K 0.32% 70
2020
Q3
$2.62M Buy
17,700
+7,960
+82% +$1.23M 0.32% 73
2020
Q2
$1.6M Buy
+9,740
New +$1.5M 0.26% 106

Other funds holding LLY

Great Valley Advisor Group's LLY Position: Q2 2026 in Review

Great Valley Advisor Group increased its Eli Lilly (LLY) stake by 5.4% in Q2 2026, buying an estimated $1.16M and bringing the position to 22,391 shares worth $26.9M. The position accounts for 0.42% of the portfolio, ranked #61.

Great Valley Advisor Group first reported a position in LLY in Q2 2020 and has held it in 25 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Great Valley Advisor Group held 22,391 shares of Eli Lilly worth $26.9M as of Q2 2026.
  • Great Valley Advisor Group bought 1,140 Eli Lilly shares in Q2 2026, an estimated $1.16M.
  • Eli Lilly made up 0.42% of Great Valley Advisor Group's portfolio in Q2 2026, its #61 holding.
  • Great Valley Advisor Group first reported a position in Eli Lilly in Q2 2020 and has held it in 25 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.